IDH2 and central nervous system cancer: In two patients (patient 5 and a previously reported patient [34]) the presence of an IDH mutation could be analyzed in both the glioma and a skeletal tumor and the same mutation (IDH1 R132H in patient 5 and IDH2 R172S in [34]) was identified in these tumors.